Cite
Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
MLA
D’Alessandro, Angelo, et al. “Metabolic Signatures of Cardiorenal Dysfunction in Plasma from Sickle Cell Patients as a Function of Therapeutic Transfusion and Hydroxyurea Treatment.” Haematologica, vol. 108, no. 12, Dec. 2023, pp. 3418–32. EBSCOhost, https://doi.org/10.3324/haematol.2023.283288.
APA
D’Alessandro, A., Nouraie, S. M., Zhang, Y., Cendali, F., Gamboni, F., Reisz, J. A., Zhang, X., Bartsch, K. W., Galbraith, M. D., Espinosa, J. M., Gordeuk, V. R., & Gladwin, M. T. (2023). Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment. Haematologica, 108(12), 3418–3432. https://doi.org/10.3324/haematol.2023.283288
Chicago
D’Alessandro, Angelo, S Mehdi Nouraie, Yingze Zhang, Francesca Cendali, Fabia Gamboni, Julie A Reisz, Xu Zhang, et al. 2023. “Metabolic Signatures of Cardiorenal Dysfunction in Plasma from Sickle Cell Patients as a Function of Therapeutic Transfusion and Hydroxyurea Treatment.” Haematologica 108 (12): 3418–32. doi:10.3324/haematol.2023.283288.